期刊文献+

肌钙蛋白Ⅰ与肌红蛋白定时定量监测在急性心肌梗死诊疗过程中的临床观察 被引量:9

Clinical Observation of Quantitative Analysis of Cardiac Troponin I and Myoglobin in Patients with Acute Myocardial Infraction
在线阅读 下载PDF
导出
摘要 根据心肌肌钙蛋白Ⅰ(cTnI)与肌红蛋白(Mb)在急性心肌梗死(AMI)发生后的定时定量分析结果比较,为AMI的早期诊断提供更灵敏、更准确的监测指标。本文采集95例AMI患者于胸痛发作0~4h、8h、12h、24h、48h、3天、5天和7天的血清,以及对照组38名的空腹血清同步进行cTnI与Mb的动态检测和比较,结果发现,AMI患者的早期0~4h Mb的灵敏度明显高于cTnI;而8h后cTnI的灵敏度和准确度明显高于Mb。 To explore the clinical value of cardiac troponinⅠ (cTnⅠ) and myoglobine (Mb) in the early diagnosis of acute myocardial infraction (AMI), the serum cTn I and Mb were detected in 95 AMI patients at various time phase including 0-4 h, 8 h, 12 h, 24 h, 48 h, 3 days, 5 days and 7 days after they got breastach, and 38 healthy controls. The results showed that the sensitivity of Mb in the diagnosis of AMI was higher than that of cTnⅠ when the AMI occurred in 0-4 hours. However, the sensitivity and accuracy of cTnⅠ in the diagnosis of .AMI were higher than that of Mb in 8 hours later.
出处 《标记免疫分析与临床》 CAS 2007年第4期210-211,220,共3页 Labeled Immunoassays and Clinical Medicine
关键词 急性心肌梗死 心肌肌钙蛋白Ⅰ 肌红蛋白 Acute myocardial infraction Cardiac troponin Ⅰ Myoglobine
  • 相关文献

参考文献7

二级参考文献59

  • 1康格非 巫向前.临床生物化学和生物化学检验(第2版)[M].北京:人民卫生出版社,1999.154.
  • 2[1]Wu A H B. Biochemical markers of cardiac damage: from traditional enzymes to cardiac-specific proteins[J]. Scand J Clin Lab Invest,1999,59(Suppl 230): 74-82.
  • 3[2]Panteghni M, Apple F S, Christenson R H, et al. Proposal from IFCC committee on Standadization of Markers of Cardiac Damage (C-SMCD): recommendation on use of biochemical markers of cardiac damage in acute coronary syndromes [J]. Scand J Clin Lab Invest, 1999,59(Suppl 230): 103-112.
  • 4[3]Wu A H,Apple F S ,Gibler W B, et al. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery disease[J]. Clin Chem,1999,45: 1104-1121.
  • 5[4]Alpert J S, Thygesen K, Antman E, et al. Myocardial infarction redefined:a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction[J]. J Am Coll Cardiol, 2000,36: 959-969.
  • 6[5]Giri S,Waters D D,Wu A H B. Pathophysiology of acute coronary syndromes In: Card iac markers. Ed. Wu A H B. New Jersey:Humana Press Inc, 1998.21-44.
  • 7[6]Winter R J, Fischer J, Bholasingh R, et al. C-reactive protein and cardiac troponin T in risk stratification:differences in optimal timing of tests early after the onset of chest pain[J]. Clin Chem,2000,46:1597-1603.
  • 8[7]Koenig W, Sund M, Frohlich M, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary, heart disease in initial healthy middle-aged men: results from the MONICA Augsburg Cohort Study, 1984 to 1992 [J]. Circulation, 1999, 99:237-242.
  • 9[8]Zimmerman J, Fromm R, Meyer D, et al. Diagnostic marker cooperative study for the diagnosis of myocardial infarction [J].Circulation, 1999,99: 1671-1677.
  • 10[9]Roberts W T, Sedrick R, Moulton L, et al. Evaluation of four automated high-sensitivity C-reactive protein methxts: implications for clinical and epidemiological applications[J]. Clin Chem, 2000,46:461-468.

共引文献557

同被引文献67

引证文献9

二级引证文献106

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部